Director Henderson buys 1,500 BDX shares for $350,430 at $233.62; holdings rise 23.0% to 8,015 shares
Director Jeffrey William Henderson purchased 1,500 shares of Becton Dickinson at $233.62 on 2025-02-10, expanding his post-transaction holdings to 8,015 shares, a 23.0% increase from his pre-transaction position of 6,515 shares. The buy occurred at a price $4.07 above the current market price of $229.55, and near the middle of the 52-week range of $220.02–$249.08. Becton Dickinson is a large-cap healthcare company ($65.9B market cap) with solid fundamentals: latest quarterly revenue of $5,168,000,000.00 and net income of $303,000,000.00, with annual revenue growth of +4.2%. The transaction represents a substantial capital commitment of $350,430.00 by a board-level insider and reflects accumulation activity in a diversified medical-device manufacturer during a period of modest positive fundamentals.